Amgen Inc. buy Piper Sandler
Start price
27.06.25
/
50%
€238.20
Target price
27.06.26
€280.34
Performance (%)
20.64%
Price
20.01.26
€282.60
Summary
This prediction is currently active. The prediction currently has a performance of 20.64%. A total of €4.76 was paid as dividends for this prediction. This prediction currently runs until 27.06.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 1.436% | 1.436% |
| iShares Core DAX® | -3.141% | 1.269% |
| iShares Nasdaq 100 | -3.518% | -1.355% |
| iShares Nikkei 225® | -3.396% | 3.283% |
| iShares S&P 500 | -2.943% | -0.533% |
Comments by Piper_Sandler for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $328.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat